Brief: Aptorum Group Collaborates With Covar Pharmaceuticals To Investigate At Least 3 Repurposed Drug Candidates For Covid-19

Aptorum

30/03/2020 15:20

March 30 (Reuters) - Aptorum Group Ltd  APM.O :
    * APTORUM GROUP COLLABORATES WITH COVAR PHARMACEUTICALS TO
INVESTIGATE AT LEAST 3 REPURPOSED DRUG CANDIDATES (SACT-COV19)
FOR CORONAVIRUS DISEASE 2019 (COVID-19) UNDER EXISTING
SMART-ACT™ PLATFORM AND ACTICULE INFECTIOUS DISEASE PLATFORM

Source text for Eikon:  ID:nBwbvCPCga 
Further company coverage:  APM.O 

 ((Briefs@thomsonreuters.com;))